Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.
about
A review of anti-VEGF agents for proliferative diabetic retinopathyShort Pulse Duration High-Power Laser Photocoagulation during Vitrectomy for Diabetic Retinopathy Reduces Postoperative InflammationTreatment of severe proliferative retinopathy and diabetic maculopathy.Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathyWhy do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy.Treatment of proliferative diabetic retinopathy with anti-VEGF agents.Diabetic retinopathy (treatment)Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.Epidemiology of diabetic retinopathy and macular oedema: a systematic review.Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathyDiabetic vitrectomy in a large type 1 diabetes patient population: long-term incidence and risk factors.Diabetic retinopathy - An update.Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.[VEGF inhibitors in vitreoretinal interventions].Surgical management of diabetic retinopathy.Retinopathy in juvenile diabetes: a 10-year (1990-2000) review.Auckland proliferative diabetic vitrectomy fellow eye study.Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practiceThe changing epidemiology of diabetic microangiopathy in type 1 diabetes.Digital Algorithmic Diabetic Retinopathy Severity Scoring System (An American Ophthalmological Society Thesis)Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.Surgical management of the late complications of proliferative diabetic retinopathy.Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.Surgical treatment for diabetic vitreoretinal diseases: a review.Long-term incidence of vitrectomy and associated risk factors in young Danish patients with Type 1 diabetes: the Danish Cohort of Paediatric Diabetes 1987.Intraocular surgery in a large diabetes patient population: risk factors and surgical results.Rate of diabetic vitrectomy in a defined geographical part of North East England.Visual outcomes following vitrectomy for diabetic retinopathy amongst Indigenous and non-Indigenous Australians in South Australia and the Northern Territory.Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration.Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
P2860
Q27025643-74057E84-CB87-425A-8DDB-E7DB094D2A1BQ27300854-538B1923-C3A4-46E9-B10E-4D4B61EBC315Q30823076-D10C70CD-48A4-4114-A1EB-EFD74F48BA7FQ30837076-67DEB319-E52D-4749-87E1-1FEDC49FE6CEQ31061150-8949CE79-17A7-499B-8F57-2891EAFADC62Q33521675-AC39AA72-1369-4C24-8612-88C8B9FF7885Q33522560-799254F4-83A0-4A89-B9FE-CA6D0F3F5B94Q33714847-CFA87F1E-2025-4BD6-A6EB-64C3DD0A74C0Q33812021-500053C7-4949-4C3E-91AB-2E4D200FE12AQ33910631-B74CFF8A-4D06-4E12-B387-033B7C320FB3Q33949871-FFFB04CD-E405-4845-8864-1A311DB31965Q34123557-32747724-2BA4-4B3B-BC4C-9714FA60AC2FQ34211317-7DABF44B-8EEC-425E-A201-3F28D16DA389Q34330907-3CE51437-E643-4654-9D7A-95767B354057Q34440571-5134E667-933C-417C-8084-4EA1AE20ED9CQ34621295-89968181-9774-470D-858C-2E61893605B1Q34657059-AF2F471B-5B1F-4C77-BD93-5D90F347B6E1Q34890223-C8871932-9AE2-459A-8F4E-FCC99C2E2091Q34957902-1822ABBB-360C-4904-A1F8-C6763A79B827Q34987495-758C8E4B-513C-4751-A056-B7BBA808C0C5Q34991648-0F0EA84B-D1E6-4B38-B68E-A7E59E431C25Q35067106-733A50C7-ADEB-44B6-8D03-392DAC3E246FQ35688919-97372E24-E3F3-493B-8C7D-A119C2920D5FQ35849693-A0CAD7E0-DACA-4E18-B11B-9C16E23EEAB6Q35886784-FA756452-AB36-4D5A-AF09-E95A8DF35583Q36178419-67DE4566-C403-4773-81CE-FC2968E3B136Q36351674-C245A93F-D712-47AC-84B5-C6F6A35F56B4Q37500522-3DD2B4BF-23EC-4358-9DC1-47AFB9B12C0EQ37688872-E5A3FD55-14D4-45E5-9ADB-8A4DFBF88C1DQ37997307-A843761F-6067-494D-8E18-FE48B665E69FQ38793330-47ABA72F-27BB-4726-A109-BB6A8EA89276Q42693552-E852F43A-3E34-490D-98BA-EB518E11ACF9Q44920544-9C401F01-A00A-40A1-950E-8C080C07D287Q47572267-C529459E-99B6-402C-B6D8-C001709DE75BQ47769001-6F2A69E0-C816-442A-B549-C4748809FDF6Q50323605-34AA786A-05DD-4927-AB8D-AFAE17329E61Q53811346-0FDCA707-7600-4B72-98AC-7E4C433CBF83Q55208760-374F0480-C008-4A19-9169-40FE34E4B3A9Q58784813-3A19821D-B85C-4BB7-A58E-6E3190BEC727
P2860
Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@ast
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@en
type
label
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@ast
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@en
prefLabel
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@ast
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@en
P2093
P1433
P1476
Pars plana vitrectomy in the E ...... inopathy Study Research Group.
@en
P2093
P304
P356
10.1016/S0161-6420(92)31779-8
P577
1992-09-01T00:00:00Z